CYTOTHERYX

Serial Number 88985401
Registration 7408844
700

Registration Progress

Application Filed
Dec 3, 2019
Under Examination
Apr 5, 2022
Approved for Publication
Feb 8, 2022
Published for Opposition
Feb 8, 2022
Registered
Jun 4, 2024

Basic Information

Serial Number
88985401
Registration Number
7408844
Filing Date
December 3, 2019
Registration Date
June 4, 2024
Published for Opposition
February 8, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 4, 2024
Registration
Registered
Classes
001

Rights Holder

Cytotheryx, Inc.

03
Address
3555 9th St NW, Suite 200
Rochester, MN 55901

Ownership History

Cytotheryx, Inc.

Original Applicant
03
Rochester, MN

Cytotheryx, Inc.

Owner at Publication
03
Rochester, MN

Cytotheryx, Inc.

Original Registrant
03
Rochester, MN

Legal Representation

Attorney
Cynthia A. Moyer
USPTO Deadlines
Next Renewal Deadline
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-04)
Due: June 04, 2030 (1793 days remaining)
Grace period ends: December 04, 2030
Additional renewal deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description
Jun 4, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 4, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 26, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 26, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 23, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Apr 23, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE
Apr 17, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 29, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Mar 29, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED
Mar 29, 2024 IUAF S USE AMENDMENT FILED
Mar 29, 2024 DRRR I DIVISIONAL REQUEST RECEIVED
Sep 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 19, 2023 EX3G S SOU EXTENSION 3 GRANTED
Sep 19, 2023 EXT3 S SOU EXTENSION 3 FILED
Sep 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 25, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 23, 2023 EX2G S SOU EXTENSION 2 GRANTED
Mar 23, 2023 EXT2 S SOU EXTENSION 2 FILED
Mar 23, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 8, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 6, 2022 EX1G S SOU EXTENSION 1 GRANTED
Sep 6, 2022 EXT1 S SOU EXTENSION 1 FILED
Sep 6, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 5, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 8, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 8, 2022 PUBO A PUBLISHED FOR OPPOSITION
Jan 19, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 5, 2022 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 3, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 7, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED
Dec 7, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN
Dec 7, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED
Dec 7, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 7, 2021 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 30, 2021 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 15, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 13, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 20, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 20, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 20, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 20, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 20, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 21, 2021 GNFR O FINAL REFUSAL E-MAILED
May 21, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
May 21, 2021 CNFR R FINAL REFUSAL WRITTEN
May 11, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 10, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED

Detailed Classifications

Class 001
Cells, namely, hepatocytes, derived from human specimens for scientific, laboratory or medical research
First Use Anywhere: Apr 19, 2023
First Use in Commerce: Apr 19, 2023

Classification

International Classes
001